Skip to main content

Advertisement

Table 1 Assessment of intratumoral inflammatory cells expressing immune related markers

From: Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Immune markers Patient 1 Patient 2 Patient 3
CD3 127a 106 185
CD8 98 83 170
Tbet 13 <  4 27
GZMB <  4 <  4 12
CD68 137 80 257
CD163 104 115 153
PDL-1 11 <  4 <  4
PD-1 <  4 6 16
  1. aNumber/mm2 of immune tumor-infiltrating cells expressing the indicated markers. See Materials and Methods for details